|1.||Hartenbach, Sabrina: 2 articles (11/2015 - 06/2014)|
|2.||Hacker, Marcus: 2 articles (11/2015 - 06/2014)|
|3.||Hartenbach, Markus: 2 articles (11/2015 - 06/2014)|
|4.||Vach, Werner: 2 articles (11/2014 - 07/2014)|
|5.||Schultze-Seemann, Wolfgang: 2 articles (11/2014 - 07/2014)|
|6.||Jilg, Cordula A: 2 articles (11/2014 - 07/2014)|
|7.||Wieser, Gesche: 2 articles (11/2014 - 07/2014)|
|8.||Rischke, H Christian: 2 articles (11/2014 - 07/2014)|
|9.||Tiling, Reinhold: 1 article (11/2015)|
|10.||Haug, Alexander R: 1 article (11/2015)|
05/01/2007 - "Improved automated synthesis of [18F]fluoroethylcholine as a radiotracer for cancer imaging."
11/01/2015 - "Maximum, mean, and peak standardized uptake value (SUV) analysis was performed, and the total intrahepatic (18)F-fluoroethylcholine positive tumor volume (FEC-PTV) and tumor-to-background ratio were assessed. "
02/01/2002 - "Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging."
02/01/2002 - "This study was aimed at developing an (18)F-substituted choline analog, (18)F-fluoroethylcholine (FECh), as a tracer of cancer detection. "
05/01/2007 - "[(18)F]Fluoroethylcholine has been recently introduced as a promising (18)F-labelled analogue of [(11)C]choline which had been previously described as a tracer for metabolic cancer imaging with positron emission tomography (PET). "
|2.||Prostatic Neoplasms (Prostate Cancer)
06/15/2014 - "This prospective trial investigates positron emission tomography (PET) with [(18)F]fluoroethylcholine (FEC) combined with endorectal magnetic resonance imaging (MRI) for the assessment of primary prostate cancer. "
09/01/2013 - "Kinetic Modeling Application to (18)F-fluoroethylcholine Positron Emission Tomography in Patients with Primary and Recurrent Prostate Cancer Using Two-tissue Compartmental Model."
01/01/2011 - "[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes."
07/01/2009 - "Recently, (11)C-choline analogues have been employed successfully in this field of imaging, leading to a growing interest in the utilization of (18)F-labeled analogues: [(18)F]fluoroethylcholine (FEC) has been demonstrated to be promising, especially in prostate cancer imaging. "
07/01/2009 - "Optimization of automated large-scale production of [(18)F]fluoroethylcholine for PET prostate cancer imaging."
|3.||Neoplasm Metastasis (Metastasis)
07/01/2014 - "Salvage was done after whole body positron emission tomography/computerized tomography with (11)C-choline or (18)F-fluoroethylcholine showed positron emission tomography positive lymph nodes but no other detectable metastasis. "
07/01/2014 - "Lymph node metastasis site and the radiotracer ((11)C-choline/(18)F-fluoroethylcholine) had no substantial impact on diagnostic accuracy. "
01/01/2010 - "[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study."
08/01/2014 - "The aim of this study is to evaluate uptake of 2-(18)F-fluoroethyl-bis(zinc(II)-dipicolylamine) ((18)F-FEN-DPAZn2) as a promising cell death imaging agent, a choline analog (18)F-fluoroethylcholine ((18)F-FECH), (18)F-fluoride as a bone imaging agent, and a glucose analog 2-(18)F-fluoro-2-deoxy-d-glucose ((18)F-FDG) in the combined S180 fibrosarcoma and turpentine-induced inflammation mice models. "
|5.||Hepatocellular Carcinoma (Hepatoma)
|1.||Choline (Choline Chloride)
|8.||1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)
|1.||Prostatectomy (Retropubic Prostatectomy)
|2.||Heterologous Transplantation (Xenotransplantation)